Anti-inflammatory effects of omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology
S Laye, A Nadjar, C Joffre, RP Bazinet… - Pharmacological …, 2018 - Elsevier
Classically, polyunsaturated fatty acids (PUFA) were largely thought to be relatively inert
structural components of brain, largely important for the formation of cellular membranes …
structural components of brain, largely important for the formation of cellular membranes …
The role of lipids in Parkinson's disease
H **coy, B Wieringa, GJM Martens - Cells, 2019 - mdpi.com
Parkinson's disease (PD) is a neurodegenerative disease characterized by a progressive
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
loss of dopaminergic neurons from the nigrostriatal pathway, formation of Lewy bodies, and …
Natural products and their bioactive compounds: neuroprotective potentials against neurodegenerative diseases
NS Mohd Sairazi… - … Based Complementary and …, 2020 - Wiley Online Library
In recent years, natural products, which originate from plants, animals, and fungi, together
with their bioactive compounds have been intensively explored and studied for their …
with their bioactive compounds have been intensively explored and studied for their …
Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges
Natural products derived from plants, as well as their bioactive compounds, have been
extensively studied in recent years for their therapeutic potential in a variety of …
extensively studied in recent years for their therapeutic potential in a variety of …
Docosahexaenoic and arachidonic acids as neuroprotective nutrients throughout the life cycle
V Sambra, F Echeverria, A Valenzuela… - Nutrients, 2021 - mdpi.com
The role of docosahexaenoic acid (DHA) and arachidonic acid (AA) in neurogenesis and
brain development throughout the life cycle is fundamental. DHA and AA are long-chain …
brain development throughout the life cycle is fundamental. DHA and AA are long-chain …
N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders
M Healy-Stoffel, B Levant - CNS & Neurological Disorders …, 2018 - ingentaconnect.com
Background & Objective: A number of neuropsychiatric disorders, including Parkinson's
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent …
disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent …
Lipid metabolism in astrocytic structure and function
Astrocytes are the most abundant glial cell in the central nervous system and are involved in
multiple processes including metabolic homeostasis, blood brain barrier regulation and …
multiple processes including metabolic homeostasis, blood brain barrier regulation and …
The interplay between gut microbiota and Parkinson's disease: Implications on diagnosis and treatment
A Varesi, LIM Campagnoli, F Fahmideh… - International journal of …, 2022 - mdpi.com
The bidirectional interaction between the gut microbiota (GM) and the Central Nervous
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …
System, the so-called gut microbiota brain axis (GMBA), deeply affects brain function and …
Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
M Silva, F Kamberovic, ST Uota, IM Kovan… - Applied Sciences, 2022 - mdpi.com
Microalgae are an untapped source of bioactive compounds with various biotechnological
applications. Several species are industrially produced and commercialized for the feed or …
applications. Several species are industrially produced and commercialized for the feed or …
New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
M Lorente-Picón, A Laguna - Biomolecules, 2021 - mdpi.com
Parkinson's disease (PD) is a multifactorial neurodegenerative disorder that currently affects
1% of the population over the age of 60 years, and for which no disease-modifying …
1% of the population over the age of 60 years, and for which no disease-modifying …